US FDA approves Cysview™ (hexaminolevulinate HCl) for detection of bladder cancer

被引：0

|

作者：

不详

机构：

来源：

FUTURE ONCOLOGY | 2010年 / 6卷 / 07期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

收藏

页码：1070 / 1070

页数：1

相关论文

共 50 条

[31] US FDA approves boceprevir for treatment of hepatitis C
不详
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2011, 9 (07) : 763 - 763
[32] US FDA approves Integrity® Coronary Stent System
不详
EXPERT REVIEW OF MEDICAL DEVICES, 2010, 7 (06) : 732 - 732
[33] US FDA approves first generic naloxone spray
Reactions Weekly, 2019, 1750 (1) : 7 - 7
[34] US FDA approves second generation female condom
不详
REPRODUCTIVE HEALTH MATTERS, 2009, 17 (33) : 193 - 193
[35] US FDA approves Kynamro™ to treat familial hypercholesterolemia
Chamberlain, Dominic
CLINICAL LIPIDOLOGY, 2013, 8 (02) : 170 - 170
[36] US FDA approves Ferriprox® to treat patients with thalassemia
Attwood, Claire
EXPERT REVIEW OF HEMATOLOGY, 2011, 4 (06) : 584 - 584
[37] US FDA approves its first Ebola vaccine
Satyanarayana, Megha
CHEMICAL & ENGINEERING NEWS, 2020, 98 (01) : 13 - 13
[38] US FDA approves lomitapide for homozygous familial hypercholesterolemia
Wilson, Hannah
CLINICAL LIPIDOLOGY, 2013, 8 (01) : 11 - 12
[39] US FDA approves azilsartan medoxomil for the treatment of hypertension
不详
EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2011, 9 (04) : 417 - 417
[40] US FDA approves Tribenzor (TM) for the treatment of hypertension
不详
EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2010, 8 (09) : 1212 - 1212

← 1 2 3 4 5 →